Keyphrases
Receptor-mediated
100%
Antigen-specific
100%
Mammalian Target of Rapamycin (mTOR)
100%
Programmed Death-ligand 1 (PD-L1)
100%
Immune Regulation
100%
Chemokine Receptor
100%
T-cell Tolerance
100%
Type 1 Diabetes Mellitus (T1DM)
75%
Type I Diabetes
75%
Protein Tyrosine Phosphatase 1B (PTP1B)
50%
SH3 Domain
50%
CXCR3
50%
Th1 Cells
50%
Dendritic Cells
25%
Phosphoinositide 3-kinase (PI3K)
25%
Signaling Events
25%
T Cells
25%
Cytoplasmic Tail
25%
Autoimmunity
25%
Pancreas
25%
Phosphatase
25%
Signal Functions
25%
Chemokine Receptor CXCR3
25%
Metabolic Pathway
25%
Target Organ
25%
T-cell Mediated
25%
Functional Defects
25%
Novel Form
25%
T Cell Suppression
25%
Diabetogenic
25%
Protein Kinase B/Akt
25%
AKT Pathway
25%
Pathogenic T Cells
25%
Medicine and Dentistry
Antigen Specificity
100%
Chemokine Receptor
100%
Immunomodulation
100%
Mammalian Target of Rapamycin Complex 1
100%
T-Cell Tolerance
100%
T Cell
75%
Insulin Dependent Diabetes Mellitus
75%
Downregulation
50%
Programmed Death 1 Ligand 1
50%
Th1 Cell
50%
Protein Kinase B
50%
Protein Tyrosine Phosphatase
50%
Dendritic Cell
25%
Upregulation
25%
Tail
25%
Autoimmunity
25%
Target Organ
25%
Phosphatase
25%
Chemokine Receptor CXCR3
25%
Immunology and Microbiology
Antigen Specificity
100%
Mammalian Target of Rapamycin Complex 1
100%
Chemokine Receptor
100%
Immunomodulation
100%
T-Cell Tolerance
100%
T Cell
75%
Phosphatase
75%
Downregulation
50%
CXCR3
50%
Th1 Cell
50%
Programmed Death 1 Ligand 1
50%
Tyrosine
50%
Dendritic Cell
25%
Autoimmunity
25%
Pancreas
25%
Chemokine Receptor CXCR3
25%
Target Organ
25%
Upregulation
25%
Biochemistry, Genetics and Molecular Biology
T Cell
100%
Mammalian Target of Rapamycin Complex 1
100%
Antigen Specificity
100%
Immunomodulation
100%
Chemokine Receptor
100%
CXCR3
50%
Downregulation
33%
Protein Tyrosine Phosphatase
33%
Protein Kinase B
33%
Upregulation
16%
Metabolic Pathway
16%
Autoimmunity
16%
Dendritic Cell
16%
Target Organ
16%
Phosphatase
16%